Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
activist investor
Biotech
Galapagos’ stock up as fund shows intent to shape its evolution
Having built a 9.9% stake, EcoR1 Capital is planning to talk to the Belgian biotech about its performance and the composition of its board.
Nick Paul Taylor
Aug 26, 2024 8:45am
Masimo sues activist investor Politan, postpones proxy vote
Jul 16, 2024 11:30am
Masimo leaders, engineers threaten to walk over proxy fight
Jul 2, 2024 1:40pm
Exelixis dips into the AI game, LIB cashes in on PCSK9
Sep 12, 2023 11:00am
Testmaker Cue Health under investor pressure to change course
Aug 31, 2023 12:01pm
AIM Immunotech once again battles activist uprising
Aug 29, 2023 10:50am
